Results 231 to 240 of about 55,893 (295)

Teplizumab in Stage 2 Type 1 Diabetes: Clinical Practice Experience on Feasibility in 3 Adult Patients

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4326-4334, May 2026.
ABSTRACT Aim To describe the first Italian experience with teplizumab administered under a compassionate use programme for adults with Stage 2 type 1 diabetes (T1D), and to evaluate its feasibility, safety and early metabolic outcomes in a real‐life clinical setting outside formal clinical trials.
V. Guarnotta   +6 more
wiley   +1 more source

Pathophysiology and Molecular Signalling in Osteoporosis: Linking Risk Factors to Bone Loss

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 9, May 2026.
ABSTRACT Osteoporosis is a prevalent skeletal disorder characterised by progressive reduction in bone mass, microarchitectural deterioration, and increased fracture susceptibility. In India, approximately one‐third of the elderly population is affected by bone‐related disorders, and the global burden of osteoporosis continues to rise.
Pramoda G.   +5 more
wiley   +1 more source

Who can safely discontinue lifelong follow‐up among patients with sporadic pheochromocytoma and paraganglioma?

open access: yesJournal of Internal Medicine, Volume 299, Issue 5, Page 615-627, May 2026.
Abstract Background Current guidelines recommend at least 10 years of follow‐up for all pheochromocytoma and paraganglioma (PPGL) patients and lifelong monitoring for high‐risk individuals. Nonetheless, data identifying patients who may not require routine lifelong follow‐up are scarce. Methods Among 999 patients with PPGL, 703 who were non‐metastatic,
Min Jeong Park   +15 more
wiley   +1 more source

Two‐Nanosensor Electrochemical Profiling of Catecholamine Vesicle Interactions With Acute and Chronic Stress Granules in Living Cells

open access: yesAngewandte Chemie, Volume 138, Issue 15, 6 April 2026.
A two‐nanosensor electrochemical strategy quantitatively distinguishes reactive oxygen species (ROS) in stress granules (SGs) from catecholamines in vesicles inside living cells. Chronic SGs formed under prolonged stress show elevated ROS and slower release, consistent with SG aging, and promote neurotransmitter loading likely through vesicle fusion ...
Hui Gu   +3 more
wiley   +2 more sources

Influence of Music on Cortisol Levels in Mechanically Ventilated Critically Ill Patients: A Systematic Review

open access: yesNursing in Critical Care, Volume 31, Issue 3, May 2026.
ABSTRACT Background Music has been proposed as a simple, non‐invasive intervention to modulate stress responses in patients undergoing invasive mechanical ventilation (IMV). Its potential impact on cortisol levels represents a promising approach to mitigating physiological stress in intensive care.
Carmen Fernández‐Álvarez   +3 more
wiley   +1 more source

Moderate maternal nutrient restriction alters type II alveolar epithelial cell density in the non‐human primate fetal lung

open access: yesExperimental Physiology, Volume 111, Issue 5, Page 2713-2728, 1 May 2026.
Abstract Restriction of fetal substrate supply has an adverse effect on surfactant maturation in the lung and thus affects the transition from in utero placental oxygenation to pulmonary ventilation ex utero. However, the consequences of reduced fetal substrate supply are dependent on the timing of gestation, severity and duration.
Mitchell C. Lock   +5 more
wiley   +1 more source

Case Report: Primary adrenal insufficiency due to bilateral adrenal infarction and antiphospholipid syndrome in Covid19 - A complicate case of cardiogenic shock. [PDF]

open access: yesFront Endocrinol (Lausanne)
Fischetti G   +15 more
europepmc   +1 more source

Plasma Renin: A Useful Marker for Mineralocorticoid Adjustment in Patients With Primary Adrenal Insufficiency. [PDF]

open access: yesJ Endocr Soc
Piazzola C   +8 more
europepmc   +1 more source

Acute Heart Failure as a First Manifestation of Primary Adrenal Insufficiency: Highly Lethal If Not Diagnosed! [PDF]

open access: yesCase Rep Endocrinol
Heidarpour M   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy